Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.019 | 0.7 |